Geneos Wealth Management’s Coherent COHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.62M Buy
10,978
+89
+0.8% +$20.4K 0.06% 320
2025
Q4
$2.01M Buy
10,889
+434
+4% +$64.9K 0.05% 352
2025
Q3
$1.13M Sell
10,455
-607
-5% -$60.5K 0.03% 459
2025
Q2
$987K Sell
11,062
-10,131
-48% -$729K 0.02% 536
2025
Q1
$1.4M Buy
21,193
+21,142
+41,455% +$1.75M 0.02% 575
2024
Q4
$4.83K Buy
+51
New +$5.1K ﹤0.01% 2344
2021
Q2
Sell
-88
Closed -$5K 2893
2021
Q1
$5K Buy
88
+13
+17% +$1.07K ﹤0.01% 2636
2020
Q4
$5K Buy
+75
New +$4.44K ﹤0.01% 2455
2020
Q2
Sell
-152
Closed -$4K 2569
2020
Q1
$4K Sell
152
-375
-71% -$12.2K ﹤0.01% 2087
2019
Q4
$17K Buy
527
+227
+76% +$7.24K ﹤0.01% 1749
2019
Q3
$10K Buy
300
+200
+200% +$7.62K ﹤0.01% 1881
2019
Q2
$3K Buy
+100
New +$3.65K ﹤0.01% 2210
2017
Q3
Sell
-680
Closed -$23K 2117
2017
Q2
$23K Hold
680
﹤0.01% 1219
2017
Q1
$24K Hold
680
﹤0.01% 1171
2016
Q4
$20K Hold
680
﹤0.01% 1179
2016
Q3
$16K Hold
680
﹤0.01% 1202
2016
Q2
$12K Hold
680
﹤0.01% 1269
2016
Q1
$14K Buy
+680
New +$13.5K ﹤0.01% 1188

Other funds holding COHR

Geneos Wealth Management's COHR Position: Q1 2026 in Review

Geneos Wealth Management increased its Coherent (COHR) stake by 0.82% in Q1 2026, buying an estimated $20.4K and bringing the position to 10,978 shares worth $2.62M. The position accounts for 0.06% of the portfolio, ranked #320.

Geneos Wealth Management first reported a position in COHR in Q1 2016 and has held it in 18 quarters since. 1,100 funds tracked by Wall St. Rank hold COHR as of Q1 2026.

  • Geneos Wealth Management held 10,978 shares of Coherent worth $2.62M as of Q1 2026.
  • Geneos Wealth Management bought 89 Coherent shares in Q1 2026, an estimated $20.4K.
  • Coherent made up 0.06% of Geneos Wealth Management's portfolio in Q1 2026, its #320 holding.
  • Geneos Wealth Management first reported a position in Coherent in Q1 2016 and has held it in 18 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Coherent as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.